tiprankstipranks
Trending News
More News >
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Income Statement

Compare
98 Followers

Design Therapeutics Income Statement

Last quarter (Q4 2025), Design Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Design Therapeutics's net income was $-16.00M. See Design Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -622.00K$ -596.00K$ -537.00K$ -466.00K$ 0.00
Operating Expenses
$ 78.84M$ 61.79M$ 77.65M$ 67.13M$ 35.83M
Depreciation and Amortization
$ 622.00K$ 596.00K$ 537.00K$ 466.00K$ 129.00K
EBITDA
$ -78.84M$ -48.99M$ -66.33M$ -62.84M$ -35.70M
Operating Income
$ -79.47M$ -62.38M$ -78.19M$ -67.59M$ -35.83M
Other Income/Expenses
$ 9.68M$ 12.79M$ 11.33M$ 4.29M$ 298.00K
Pretax Income
$ -69.79M$ -49.59M$ -66.86M$ -63.31M$ -35.53M
Net Income
$ -69.79M$ -49.59M$ -66.86M$ -63.31M$ -35.53M
Per Share Metrics
Basic EPS
$ -1.22$ -0.88$ -1.19$ -1.14$ -0.77
Diluted EPS
$ -1.22$ -0.88$ -1.19$ -1.14$ -0.77
Weighted Average Shares Outstanding
57.33M 56.59M 55.98M 55.71M 45.94M
Weighted Average Shares Outstanding (Diluted)
57.33M 56.59M 55.98M 55.71M 45.94M
Currency in USD

Design Therapeutics Earnings and Revenue History